Novozymes A/S (0Q4U.IL)
- Previous Close
487.15 - Open
482.65 - Bid 475.50 x --
- Ask 493.90 x --
- Day's Range
482.65 - 488.30 - 52 Week Range
368.60 - 488.97 - Volume
79,077 - Avg. Volume
292,730 - Market Cap (intraday)
133.677B - Beta (5Y Monthly) 0.44
- PE Ratio (TTM)
39.20 - EPS (TTM)
12.32 - Earnings Date Aug 21, 2025
- Forward Dividend & Yield 10.20 (3.59%)
- Ex-Dividend Date Oct 11, 2023
- 1y Target Est
411.63
Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company offers baking, beverages, dairy, starch, and protein solutions for the food and beverage industry; laundry, dishwashing, and professional cleaning solutions for the household care industry; agriculture solutions, including crop production, and animal health and nutrition solutions; bioyield and biocontrol solutions for crops; and grain and technical processing solutions, as well as bio energy solutions for liquefaction, saccharifaction, fermentation, fiber conversion, and biomass conversion. It also provides textile solutions, such as biopreparation, biopolishing, bleach clean-up, denim abrasion and finishing, and desizing solutions. In addition, the company offers solutions for pulp & paper, including fiber modification, bleach boosting, deposit control, starch modification, and deinking; leather solutions comprising acid bating, area expansion, bating, degreasing, soaking, and unhairing and liming; and water and waste management solutions, which consist of bioaugmentation, biogas, and sludge management. Further, it provides pharmaceutical solutions, including lipases, immobilized lipases, and proteases for biocatalysis, as well as rTrypsin for cell culture; and human health and protein solutions. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.
www.novozymes.com6,852
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 0Q4U.IL
View MorePerformance Overview: 0Q4U.IL
Trailing total returns as of 6/13/2025, which may include dividends or other distributions. Benchmark is OMX Copenhagen 25 Index (^OMXC25) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0Q4U.IL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0Q4U.IL
View MoreValuation Measures
Market Cap
226.10B
Enterprise Value
236.86B
Trailing P/E
65.40
Forward P/E
32.05
PEG Ratio (5yr expected)
0.27
Price/Sales (ttm)
7.50
Price/Book (mrq)
2.68
Enterprise Value/Revenue
7.83
Enterprise Value/EBITDA
48.49
Financial Highlights
Profitability and Income Statement
Profit Margin
19.31%
Return on Assets (ttm)
10.14%
Return on Equity (ttm)
26.21%
Revenue (ttm)
17.74B
Net Income Avi to Common (ttm)
3.42B
Diluted EPS (ttm)
12.32
Balance Sheet and Cash Flow
Total Cash (mrq)
1.05B
Total Debt/Equity (mrq)
58.88%
Levered Free Cash Flow (ttm)
1.02B